Design and radiosynthesis of class-IIa HDAC inhibitor with high molar activity via repositioning the 18F-radiolabel

Sulan Xu1,2, Chun-Han Huang1,2,3, Christopher Eyermann1,4

  • 1Stony Brook Cancer Center, Stony Brook, Long Island, NY, 11794, USA.

Scientific Reports
|July 2, 2024
PubMed

Related Concept Videos